Congress trading in SNPS
9 members of Congress have disclosed trading SNPS — 3 purchases and 7 sales worth an estimated $112,500. Most recent disclosure: Dec 31, 2025.
See who in Congress traded SNPS →About Synopsys, Inc.
Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; FPGA design products that are programmed to perform specific functions; synopsys technology computer-aided design (TCAD), mask synthesis, and manufacturing analytic solutions; and AI-driven EDA solutions. It also provides pre-verified and silicon-proven IP solutions, logic libraries and embedded memories, processor and security solutions, IP Offerings for the automotive market, SOC infrastructure IP, data path and building block IP, and mathematical and floating-point components. Synopsys, Inc. has a strategic collaboration with Arm Holdings plc for development of AGI CPU that provides solutions across its full-stack design portfolio including EDA, interface IP, and hardware-assisted verification (HAV). The company was incorporated in 1986 and is headquartered in Sunnyvale, California.
SNPS Key Statistics
SNPS in plain English
- P/E ratio (104.2) — how many dollars you pay for each $1 of SNPS's yearly profit. That's high, so the market expects strong growth (and you're paying up for it).
- ROE (3.82%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (8.91%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend — SNPS doesn't pay a meaningful dividend; the return here comes from the share price, not cash payouts.
Compare SNPS with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.